A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous.

Slides:

Advertisements

Similar presentations

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Advertisements

Carotid artery stenting may be performed safely in patients with radiation therapy- associated carotid stenosis without increased restenosis or target.

Restenosis in gold-coated renal artery stents

Revascularization for acute mesenteric ischemia

Comparison of EVAR and open repair in patients with small abdominal aortic aneurysms: Can we predict results of the PIVOTAL trial? Purandath Lall, MBBS,

Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions Tomoharu Dohi,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Kenneth Ouriel, MD, Richard J. Fowl, MD, Mark G

A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease Bibombe P. Mwipatayi, MMed (Surg), FCS (SA), FRACS,

Endovascular repair of abdominal aortic aneurysm in octogenarians: An analysis based on EUROSTAR data Conrad Lange, MD, Lina J. Leurs, MSc, Jaap Buth,

Early and long-term results of carotid endarterectomy in diabetic patients Walter Dorigo, MD, Raffaele Pulli, MD, Giovanni Pratesi, MD, Aaron Fargion,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Mark G. Davies, MD, PhD, MBA, Wael E. Saad, MD, Jean X

Louis L. Nguyen, MD, MBA, MPH Journal of Vascular Surgery

Incorporating simulation in vascular surgery education

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

The first operation on the profunda femoris artery

Lowell S. Kabnick, MD Journal of Vascular Surgery

Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair Athanasios Saratzis, MBBS, MRCS,

IP135. Telehealth Electronic Monitoring to Reduce Postdischarge Complications and Surgical Site Infections After Arterial Revascularization With Groin.

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Mesenteric stenting for chronic mesenteric ischemia

Durability and survival are similar after elective endovascular and open repair of abdominal aortic aneurysms in younger patients Kevin Lee, MD, Elaine.

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: A randomized controlled trial

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Michael P. Harlander-Locke, BS, Liv K. Harmon, MD, Peter F

Christopher J. Smolock, MD, Javier E

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery Michael.

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

Diabetes is not a predictor of outcome for carotid revascularization with stenting as it may be for carotid endarterectomy Gianbattista Parlani, MD,

National trends in utilization, mortality, and survival after repair of type B aortic dissection in the Medicare population Douglas W. Jones, MD, Philip.

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Outcomes of renal artery angioplasty and stenting using low-profile systems Brian W. Nolan, MD, Marc L. Schermerhorn, MD, Erin Rowell, MD, Richard J.

Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia

Population-based analysis of inpatient vascular procedures and predicting future workload and implications for training Jeffrey Jim, MD, Pamela L. Owens,

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia Panagiotis Kougias, MD, Donald Lau, BS,

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Primary stenting of the superficial femoral and popliteal artery

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms Barbara Rantner, MD,

Early versus delayed carotid endarterectomy in symptomatic patients

Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Eric K

Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss Mark G. Davies, MD, PhD, Wael E. Saad, MD, Eric.

Jorg L. de Bruin, MD, Annette F. Baas, MD, PhD, Martijn W

Effects of Statin and Antiplatelet Therapy Noncompliance and Intolerance on Patient Outcomes Following Vascular Surgery Johnston L. Moore, Zdenek Novak,

David L. Dawson, MD, Jennifer Meyer, RCIS, Eugene S

Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery Russell C. Lam,

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

Results of a randomized clinical trial of external beam radiation to prevent restenosis after superficial femoral artery stenting Eric Therasse, MD,

Glauco Milio, MD, Chiara Minà, MD, Valentina Cospite, MD, Piero L

Christopher J. Abularrage, MD, Mark F. Conrad, MD, MMSc, Lauren A

Long-term outcomes of patients undergoing endovascular infrainguinal interventions with single-vessel peroneal artery runoff Christopher J. Abularrage,

Christopher L. Skelly, MD, Katherine Gallagher, BS, Ronald M

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Journal of Vascular Surgery

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Midterm outcomes of the Zenith Renu AAA Ancillary Graft

Endovascular brachytherapy for renal artery in-stent restenosis

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

IP109. The Learning Curve of Transcarotid Artery Revascularization

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Influence of anesthesia type on outcome after endovascular aortic aneurysm repair: An analysis based on EUROSTAR data Volker Ruppert, MD, Lina J. Leurs,

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Clinical outcomes after closed, staged, and open forefoot amputations

Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis Ali F. AbuRahma,

Presentation transcript:

A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous revascularization Hosam El Sayed, MD, PhD, Richard Kerensky, MD, Michael Stecher, MD, Prasant Mohanty, MBBS, Mark Davies, MD, PhD Journal of Vascular Surgery Volume 63, Issue 1, Pages 133-141.e1 (January 2016) DOI: 10.1016/j.jvs.2015.08.069 Copyright © 2016 Society for Vascular Surgery Terms and Conditions

Fig 1 Patient flow diagram. Journal of Vascular Surgery 2016 63, 133-141.e1DOI: (10.1016/j.jvs.2015.08.069) Copyright © 2016 Society for Vascular Surgery Terms and Conditions

Fig 2 The Kaplan-Meier curve compares the cumulative freedom from restenosis at long-term follow-up. The trend in the treatment benefit observed at 4 months after the procedure (restenosis rates of 9% in the standard of care [SOC] group and 0% in the Xilonix group) diminished during the course of the study. At 12 months, the restenosis rates were not different between the Xilonix and SOC groups; 27% (6 of 22) Xilonix patients and 24% (5 of 21) SOC patients experienced target vessel restenosis (log-rank, P = .79). Journal of Vascular Surgery 2016 63, 133-141.e1DOI: (10.1016/j.jvs.2015.08.069) Copyright © 2016 Society for Vascular Surgery Terms and Conditions